CODEXIS, INC. REDWOOD CITY, Calif., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it will report fourth quarter and full year 2014 financial results after market close on Tuesday, March 3, 2015. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern Time (1:30 Pacific Time) to discuss financial results and provide a company update.
| Live Call: | U.S. | 800 798 2864 |
| International | 617 614 6206 | |
| Passcode | 25449393 | |
| Live Webcast: | Codexis IR Website | |
| The webcast will be archived for 90 days. | ||
| Replay: | U.S. | 888 286 8010 |
| International | 617 801 6888 | |
| Passcode | 94888240 | |
| The replay will be available for 48 hours | ||
About Codexis, Inc.
Codexis, Inc. is a leading developer of biocatalysts for pharmaceutical and fine chemical production. Codexis' proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development – from research to manufacturing. For more information, see www.codexis.com.
| CONTACT: | Investors |
| LHA | |
| Jody Cain, 310 691 7100 | |
| jcain@lhai.com | |
| Media | |
| Notch Communications | |
| Kate Whelan, +46 (0)70 238 11 49 | |
| Kate.whelan@notchcommunications.co.uk |
